Rockpointe Corporation

Don't forget to register!! Last chance to join us for this year's Kidney Summit and hear from Dr. Jay Wish, Dr. Matthew Weir, and nurse Christine Chmielewski about lowering the burden of anemia. We will also be joined by the American Kidney Fund and Robert Bl**er from Renal Physicians Association to discuss resources for you and your patients, and kidney reimbursements. www.rockpointe.com/KidneySummit to learn more.

Kidney Summit 2022 | Rockpointe CME/CNE-certified, ABIM MOC/MIPS-eligible Activity TO REGISTER: Click here to complete your registration. If you will be...

Going to Chicago this weekend for ? Join us for breakfast live or virtually, Sunday morning, Nov 6th, at 6:00 AM and learn about Obesity as a Cardiovascular Risk Factor from Drs. Ian Neeland, Fatima Cody Stanford, and Jean-Pierre Després . https://bit.ly/3DwqG5w

Going to Chicago for ? Join us for breakfast live or virtually, Sunday morning, Nov 6th, at 6:00 AM and learn about Obesity as a Cardiovascular Risk Factor from Drs. Ian Neeland, Fatima Cody Stanford, and Jean-Pierre Després . https://bit.ly/3DwqG5w

Don't miss out, register today! The 2022 Kidney Summit featuring Dr. Matthew Weir, Dr. Jay Wish, and Christine Chmielewski, CRNP along with American Kidney Fund and Robert Bl**er from Renal Physicians Association. www.rockpointe.com/KidneySummit

Kidney Summit 2022 | Rockpointe CME/CNE-certified, ABIM MOC/MIPS-eligible Activity TO REGISTER: Click here to complete your registration. If you will be...

The 2022 Kidney Summit will familiarize nephrology clinicians with the etiology of anemia in CKD, the effects on health outcomes and quality of life, and discuss the function, advantages, and limitations of current management strategies. We will be joined by the American Kidney Fund and Robert Bl**er from Renal Physicians Association for discussions about the many resources available to clinicians and patients, and kidney disease reimbursements. Register today at www.rockpointe.com/KidneySummit and choose your preferred date.

Kidney Summit 2022 | Rockpointe CME/CNE-certified, ABIM MOC/MIPS-eligible Activity TO REGISTER: Click here to complete your registration. If you will be...

2022 Kidney Summit. Don't forget to register, happening today! Learn from Dr. Matthew Weir, Dr. Jay Wish, NP Christine Chmielewski, the American Kidney Fund, and Robert Bl**er from Renal Physicians Association. https://bit.ly/3EcFcjo

Join Drs. Matthew Weir, Jay Wish, and NP Christine Chmielewski to learn about Lowering the Burden of Anemia in patients with CKD. The American Kidney Fund and Robert Bl**er from Renal Physicians Association will also be joining us! Register today to earn . www.rockpointe.com/KidneySummit

Happening this Saturday, don't forget to register! Learn from Drs. Doreen Addrizzo-Harris and Charles L. Daley about nontuberculous mycobacterial infections and how to identify early clinical signs of NTM and how to communicate with patients regarding their management.

The introduction of CDK4/6 inhibitors into the treatment of HR-positive, HER2-negative metastatic breast cancer (mBC) resulted in a paradigm shift, and these agents are now considered the gold standard for first-line treatment. Learn more from Drs. Megan Kruse and Ruth O'Regan as they give an in-depth evaluation of current clinical trial data and real-world experience with available CDK4/6 inhibitors.

CDK4/6 Inhibitors in the Real World: Evaluating the Evidence in HR-positive/HER2-negative Metastatic Breast Cancer (webcourse) - Rockpointe | Continuing Medical Education Company | CME/CE CDK4/6 Inhibitors in the Real World: Evaluating the Evidence in HR-positive/HER2-negative Metastatic Breast Cancer (webcourse) Format: Webcourse Credit(s): 1.00 (60 min) Release Date: Aug 16, 2022 Expiration Date: Aug 16, 2023 Credit Type(s): Physicians – AMA PRA Category 1 Credit(s) ™Physicians...

The incidence of nontuberculous mycobacterial infections caused by Mycobacterium avium complex (NTM-MAC) have increased dramatically in recent decades. Learn about guideline-based diagnosis and treatment of NTM to improve clinician skill in identifying early clinical signs of NTM-MAC, diagnosis, treatment selection, and effective communication with patients regarding NTM-MAC management. www.rockpointe.com/NTMReg

Don't miss out! Only one more day to hear Drs. Martin S. Maron and Ethan Rowin discuss hypertrophic cardiomyopathy (HCM), the most common monogenic cardiovascular disease. Learn about the recommended diagnostic testing and the evidence-based guidelines for managing these patients. http://www.rockpointe.com/HypertrophicCardiomyopathy